At a glance
- Originator Pfizer
- Class Antibacterials; Antineoplastics; Quinolones
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 14 Feb 1995 No-Development-Reported for Bacterial infections in USA (Unknown route)